Sharemaestro company-news research for Almirall, S.A. (ALM), showing current tone, evidence confidence, direct company coverage, sector and industry context, completed price response and the source headlines used on the page. Scores describe published news evidence. Confidence describes the amount, freshness, source breadth and direct company relevance of that evidence. Price context is shown separately.

MCE Spain Provisional evidence

Company news sentiment

ALM news sentiment

Almirall, S.A.

Company headlines from the last 30 days, weighted by freshness, relevance, publisher quality and the strength of the wording. Price is shown separately.

Full chart Weekly report RSS feed
30-day score51Neutral is 50
Early balanced news score 22/100 evidence confidence 80% direct company focus 2 current stories across 2 publishers
Latest weekly closeEUR 10.84week of 7 Aug 2026
Main news subjectAnalyst action58/100 share of current news
News data statusHealthy1 duplicate stories removed

Current company news

Early balanced news score

2 company-specific stories are available, but there are not yet enough fresh stories from separate publishers for a firm reading.

Observed headline tone58/100 Published 30-day score51/100

Older, less relevant and less reliable stories count for less. Confidence is shown separately.

Latest source headline Almirall Enters Collaboration With CrystalO for the Discovery and Development of Novel Small Molecules in Medical Dermatology finance.yahoo.com · 10 Aug 2026 06:00

What supports the score

Direct evidence

2 current stories are mapped specifically to ALM.

What limits the score

Source breadth

Only 2 publishers currently contribute to the measured read.

Too little evidence

The stories agree, but freshness-weighted evidence is only 0.062.

Confidence

Confidence is 22/100, below the threshold for a firm score.

51/100
News scoreEarly balanced news score
22/100
Confidencethin evidence
80%/100
Company news2 company stories
98/100
Story agreement2/100 difference

News history

Daily score and story count over 30 days

Daily weighted evidence
02 Aug: 1 stories10 Aug: 1 stories 02 Aug: tone 50, 1 stories10 Aug: tone 58, 1 stories 95505
15 Jul30 Jul13 Aug
News scoreStory count50 baseline

Confidence

How reliable the score is

Separate from direction

Confidence uses the amount of news, separate publishers, direct company relevance, freshness and agreement. A high or low score is not automatically reliable.

Amount of evidence1
0.062 after freshness weighting
Source breadth40
2 independent publishers
Company relevance80
share tied directly to this company
Freshness50
recency-weighted evidence
Agreement98
how closely stories agree
Publisher mix15
less reliance on one publisher

Price and news history

News score and weekly price over 26 weeks

Early company-news score

Company-specific news is present, but the evidence has not yet earned enough independent, fresh information weight for price confirmation to be treated as a firm signal.

One scoring method across the chart.Stored company headlines are recalculated at each weekly point with the current 30-day freshness weighting. Old published snapshots are left unchanged.
13 Feb 2026: close 13.18, indexed 100.020 Feb 2026: close 13.2, indexed 100.127 Feb 2026: close 12.67, indexed 96.106 Mar 2026: close 11.79, indexed 89.413 Mar 2026: close 11.18, indexed 84.820 Mar 2026: close 11.24, indexed 85.227 Mar 2026: close 11.91, indexed 90.303 Apr 2026: close 12.12, indexed 91.910 Apr 2026: close 12.79, indexed 97.017 Apr 2026: close 12.57, indexed 95.424 Apr 2026: close 12.52, indexed 94.901 May 2026: close 12.38, indexed 93.908 May 2026: close 11.77, indexed 89.315 May 2026: close 11.32, indexed 85.922 May 2026: close 11.6, indexed 88.029 May 2026: close 11.38, indexed 86.305 Jun 2026: close 11.24, indexed 85.312 Jun 2026: close 11.34, indexed 86.019 Jun 2026: close 11.12, indexed 84.326 Jun 2026: close 11.28, indexed 85.603 Jul 2026: close 11.4, indexed 86.510 Jul 2026: close 11.24, indexed 85.317 Jul 2026: close 10.68, indexed 81.024 Jul 2026: close 11.2, indexed 84.931 Jul 2026: close 11.12, indexed 84.307 Aug 2026: close 10.84, indexed 82.2 07 Aug 2026: news score 50, close 10.84, 1 stories50
13 Feb15 May07 Aug
Weekly close, indexedSentiment score
26-week price-17.8%latest close 10.84
News score changeNot measuredfirst to latest comparable week
One-week response-2.5%Price reacting lower
Fair-value position+10.2%Near fair-value range
WeekNews scoreCloseWeekly move
07 Aug 202650EUR 10.84-2.5%
Provisional evidence

News subjects

What is shaping the score

Analyst action
Earnings581 stories · 50%
Analyst action501 stories · 50%

Source mix

Where the evidence comes from

15/100 independence
finance.yahoo.com581 stories · 50%
marketscreener.com501 stories · 50%

Recurring subjects

Subjects appearing most often

Current evidence
Medical Dermatology1MEDICAL-DERMATOLOGY1Drug Discovery1DRUG-DISCOVERY1Collaboration1COLLABORATION1

Earlier readings

How the score has changed

3 comparable readings · 11 days
Past and present use the same method.Each point recalculates the previous 30 days of stored company headlines with today's scoring rules. The original stored snapshots remain unchanged.
Comparable move+150 to 51 · Broadly stable
Observed range50–5250 is the neutral baseline
Evidence depth2stories at latest stored reading · +1
Confidence21/100Provisional · -5
02 Aug50 neutral13 Aug 20:51
ConstructiveBalanced or withheldCautious

Changes in the stored score

Scores are rebuilt from stored headlines with the current 30-day method. Days with no change are collapsed.

ObservedScoreMoveConfidenceStoriesStatus
13 Aug 20:5151-121/100 (-6)2 (0)Provisional
10 Aug 23:5952+227/100 (+1)2 (+1)Provisional
02 Aug 23:5950Start26/1001Provisional

Source headlines

The news behind the score

Showing 1-2 of 2

Only company-specific stories enter this score. The latest 30 days are shown newest first, with newer stories weighted more heavily and duplicate coverage combined.

#158Tone
finance.yahoo.comDirect company coverage

Almirall Enters Collaboration With CrystalO for the Discovery and Development of Novel Small Molecules in Medical Dermatology

The collaboration will leverage CrystalO's ion channel small-molecule drug discovery platform and Almirall's expertise in skin science to jointly advance an innovative small-molecule program in medical dermatology. CrystalO will conduct candidate discovery, optimization, IND-enabling studies and early clinical development to deliver clinical proof of concept (POC), while Almirall will lead subsequent global development, manufacturing and commercialization holding exclusive rights outside mainland China. The agreement further expands Almirall's innovation footprint in China, based on the compan

COLLABORATIONCollaborationDRUG-DISCOVERYDrug DiscoveryMEDICAL-DERMATOLOGYMedical Dermatology
Published
10 Aug 2026 06:00
News subject
Earnings
Why this score
Positive financial language
Company focus
Shared story · 78%
How it is used
Direct company coverage
Weighted influence
High · 92.1% · 3.6d old
Duplicates
2 consolidated

Earlier company news

ALM news archive

Archive building

Stored newest first for historical research. It starts after the newest three pages above and then continues through older news. Each archive page is loaded only when it is opened.

Older news is kept in the archive

The archive will appear as more ALM headlines are stored.

How the page works

How to read the score

The score shows direction

It describes the weighted balance of qualifying headlines. A score of 50 can mean balanced news or that there is not enough evidence; the status label explains which.

Confidence is separate

Confidence measures depth, source breadth, direct relevance, freshness and agreement. It does not rise merely because the tone is extreme.

Price is confirmation

Weekly price response, trend and fair-value position test whether the market is accepting or rejecting the news. They never rewrite the news score.

What the page does

It measures news already published. It is not a forecast, recommendation or price target.

Evidence context